The novel exon 11 mutation of BRCA1 gene in a high-risk family

Neoplasma

Volumn 50, Issue 6, 2003, Pages 403-407

  Ciernikova S ^a   Tomka, M ^a   Sedlakova O ^a   Reinerova M ^a   Stevurkova V ^a   Kovac M ^a   Cente M ^a   Ilencikova D ^b   Bella, V ^b   Zajac, V ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b CANCER RESEARCH INSTITUTE   (Slovakia)

Author keywords

APC gene; BRCA1 gene germline mutations; Breast and ovarian cancer; Heteroduplex analysis (HDA); K ras oncogene; Single strand conformation polymorphism (SSCP); TP53 gene

Indexed keywords

ADULT; ARTICLE; AUTOANALYZER; BREAST CANCER; CANCER SUSCEPTIBILITY; CASE REPORT; DISEASE COURSE; DNA DETERMINATION; EXON; FAMILIAL CANCER; FAMILY; FEMALE; GENE ACTIVATION; GENE DELETION; GENE INACTIVATION; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GERM LINE; HETERODUPLEX ANALYSIS; HIGH RISK POPULATION; HUMAN; HUMAN CELL; ONCOGENE; ONCOGENE K RAS; OVARY CANCER; PEDIGREE; PRESCHOOL CHILD; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 10744231033     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. CORNELIS RS, VAN VLIET M, VAN DER VIJVER MJ, VASEN HF, VOUTE PA, TOP B, KHAN PM, DEVILEE P, CORNELISSE CJ. Three germline mutations in the TP53 gene. Hum Mutat 1997; 9: 157-163.
2. EASTON DF, BISHOP DT, FORD D, CROCKFORD GP. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993; 52: 678-701.
3. FALKENBERRY SS, LEGARE RD. Risk factors for breast cancer. Obstet Gynecol Clin North Am 2002; 29: 159-172.
4. FUJITA M, ENOMOTO T, MURATA Y. Genetic alterations in ovarian carcinoma: with specific reference to histological subtypes. Mol Cell Endocrinol 2003; 202: 97-99.
5. GOLDGAR DE, TEARE D, SHUGART Y, STRATTON M, EASTON D. Candidate gene analysis and preliminary genomic search results for mapping of non-BRCA1/2 breast cancer genes. Am J Hum Genet 1997; 61: 358-365.
6. KAINU T, JUO SH, DESPER R, SCHAFFER AA, GILLANDERS E, ROZENBLUM E, FREAS-LUTZ D, WEAVER D, STEPHAN D, BAILEY-WILSON J, KALLIONIEMI OP, TIRKKONEN M, SYRJAKOSKI K, KUUKASJARVI T, KOIVISTO P, KARHU R, HOLLI K, ARASON A, JOHANNESDOTTIR O, BERGTHORSSON JT, JOHANNSDOTTIR H, EGILSSON V, BARKARDOTTIR RB, JOHANNSSON O, HARALDSSON K, SANDBERG T, HOLMBERG E, GRONBERG H, OLSSON H, BORG A. VEHMANES P, EEROLA H, HEIKKILA P, PYRHONEN S, NEVANLINNA H. Somatic deletions in hereditary breast cancers implicate 13q21 as putative novel breast cancer susceptibility locus. Proc Natl Acad Sci USA 2000; 97: 9603-9608.
7. KIRCHHOFF T, ZAJAC V, KRIŽAN P, REPISKÁ V, ŠTEVURKOVÁ V, FRIEDL W. Identification of APC exon 15 mutations in families suspected of familial adenomatous polyposis (FAP). Folia Biol. (Praha) 1997; 43: 205-209.
8. MARTIN AM, WEBER BL. Genetic and hormonal risk factors in breast cancer. J Natl Cancer Inst 2000; 92: 1126-1135.
9. MIKI Y, SWESSEN J, SHATTUCK-EIDENS D, FUTREAL PA, HARSHMAN K, TAVTIGIAN S, LIU Q, COCHRAN C, BENNET LM, DING W, BELL R, ROSENTHAL J. Astrong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71.
10. MILNER J, PONDER B, HUGHES-DAVIES L, SELTMANN M, KOUZARIDES T. Transcriptional activation functions in BRCA2. Nature 1997; 386: 772-773.
11. ORBAN TI, CSOKAY B, OLAH E. Sequence alterations can mask each other's presence during screening with SSCP or heteroduplex analysis: BRCA genes as examples. BioTechniques 2000; 29: 94-98.
12. ROSEN EM, FAN S, GOLDBERG ID. BRCA1 and prostate cancer. Cancer Invest 2001; 19: 396-412.
13. SCULLY R, ANDERSON SF, CHAO DM, WEI W, YE L, YOUNG RA, LIVINGSTON DM, PARVIN JD. BRCA1 is acomponent of the RNA polymerase II holoenzyme. Proc Nat Acad Sci 1997; 94: 5605-5610.
14. SCULLY R, CHEN J, PLUG A, XIAO Y, WEAVER D, FEUNTEUN J, ASHLEY T, LIVINGSTON DM. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 1997; 88: 265-275.
15. SHIRI-SVERDLOV R, OEFNER P, GREEN L, BARUCH RG, WAGNER T, KRUGLIKOVA A, HAITCHICK S, HOFSTRA RM, PAPA MZ, MULDER I, RIZEL S, BAR SADE RB, DAGAN E, ABDEEN Z, GOLDMAN B, FRIEDMAN E. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer. Hum Mutat 2000; 16: 491-501.
16. THOMPSON LH, SCHILD D. Homologous recombinational repair of DNA ensures mammalian chromosome stability. Mutat Res 2001; 477: 131-153.
17. TOMKA M, SEDLAKOVA O, REINEROVA M, VESELOVSKA Z, STEVURKOVA V, BARTOSOVA Z, ZAJAC V. Mutation screening of the BRCA1 gene in Slovak patients. Neoplasma 2001; 48: 541-455.
18. VOGELSTEIN B, KINZLER KW. The genetic basis of human cancer. The McGraw-Hill companies USA, 1998.
19. VARLEY JM. Germline TP53 mutations and Li-Fraumeni syndrome. Hum Mutat 2003; 21: 313-320.
20. WAGNER TMU, MOSLINGER RA, MUHR D, LANGBAUER G, HIRTENLEHNER K, CONCIN H, DOELLER W, HAID A, LANG AH, MAYER P, ROPP E, KUBISTA E, AMIRIMANI B, HELBICH T, BECHERER A, SCHEINER O, BREITENEDER H, BORG A, DEVILEE P, OEFNER P, ZIELINSKI C. BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics. Int J Cancer 1998; 77: 354-360.
21. WOOSTER R, BIGNELL G, LANCASTER J, SWIFT S, SEAL S, MANGION J, COLLINS N, GREGORY S, GUMBS C, MICKLEM G, BARFOOT R, HAMOUDI R, PATEL S, RICE C, BIGGS P, HASHIM Y, SMITH A, CONNOR F, ARASON A, GUDMUNDSSON J, FICENEC D, KEISELL D, FORD D, TONIN P, BISHIP DT, SPURR NK, PONDER BAJ. EELES R, PETO J, DEVILEE P, CORNELISSE C, LYNCH H, NAROD S, LENOIR G, EGILSSON V, BARKAVOTTIR RB, EASTON DF, BENTLEY DR, FUTREAL PA, ASHWORTH A, STRATTON MR. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995; 378: 789-792.
22. ZAJAC V, TOMKA M, ILENCIKOVA D, MAJEK P, STEVURKOVA V, KIRCHHOFF T. A double germline mutations in the APC and p53 genes. Neoplasma 2000; 47: 335-341.